Diabetes / 29.08.2025

MedicalResearch.com Interview with: [caption id="attachment_70452" align="alignleft" width="150"]Dr. Simon Berry MRCP, MbChBClinical Research Fellow in Diabetes School of Medicine and Population Health Sheffield Teaching Hospitals NHS Foundation Trust University of Sheffield Sheffield, UK Dr. Berry[/caption] Dr. Simon Berry MRCP, MbChB Clinical Research Fellow in Diabetes School of Medicine and Population Health Sheffield Teaching Hospitals NHS Foundation Trust University of Sheffield Sheffield, UK   MedicalResearch.com: What is the background for this study? What are the main findings? Response: Obesity is an increasing problem in people with type 1 diabetes, augmenting cardiovascular risk and leading to issues with insulin resistance, which make it harder to match insulin injections to carbohydrate intake. Tirzepatide is licensed for the management of type 2 diabetes and obesity. Our study looked at people with type 1 diabetes who had been prescribed tirzepatide off-license. It found that after starting tirzepatide, there was significant weight loss, improvements in glucose levels (HbA1c and time in range on continuous glucose monitoring) and reductions in insulin requirements. Side effects such as nausea and vomiting were common but generally tolerated and importantly, there was no increase in the frequency of low blood glucose levels (hypoglycaemia) or any cases of pancreatitis.

Diabetes / 14.01.2025

Diabetes is one of the most prevalent chronic conditions globally, affecting millions of people. Whether it's Type 1 or Type 2 diabetes, managing blood sugar levels effectively is crucial to preventing complications and maintaining a high quality of life. With advancements in medical science, the landscape of diabetes management has evolved significantly, offering patients more options than ever before.  [caption id="attachment_65918" align="aligncenter" width="333"]diabetes-medications-types.jpg Photo by Nataliya Vaitkevich[/caption]

Understanding Type 1 and Type 2 Diabetes

Before diving into modern medications, it's essential to understand the fundamental differences between Type 1 and Type 2 diabetes, as these differences often dictate the type of treatment required.

Type 1 Diabetes

Type 1 diabetes is an autoimmune condition where the body mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. This results in little or no insulin production, making individuals with Type 1 diabetes reliant on insulin therapy to regulate their blood glucose levels. It usually manifests early in life, although it can develop at any age. Managing Type 1 diabetes requires careful monitoring and adjusting of insulin doses, often with the help of advanced tools like insulin pumps and continuous glucose monitors (CGMs).

Type 2 Diabetes

Type 2 diabetes, on the other hand, is primarily characterized by insulin resistance, where the body does not respond to insulin as effectively as it should. Over time, the pancreas may struggle to produce enough insulin to overcome this resistance, leading to elevated blood glucose levels. Type 2 diabetes is more common in adults, though increasing rates are now being observed in younger populations due to lifestyle factors like poor diet and lack of exercise. In addition to lifestyle changes, medications are often required to help manage the condition. Understanding these distinctions is crucial because it helps in determining the most appropriate medications and treatment plans for each type of diabetes.
Weight Research / 09.09.2024

Tirzepatide is an innovative medication recently making waves in the treatment of type 2 diabetes and obesity. Known by its brand names, Mounjaro and Zepbound, this medication is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. While its efficacy in managing blood glucose levels and supporting weight loss is noteworthy, it’s crucial for patients and healthcare providers to fully understand the potential side effects associated with tirzepatide. This article delves into the detailed aspects of tirzepatide side effects, providing key insights for those considering this medication.

What is Tirzepatide?

Tirzepatide belongs to a new class of medications designed to manage blood sugar in adults with type 2 diabetes. It works by mimicking the action of two incretin hormones—GIP and GLP-1—which help regulate insulin secretion, slow down gastric emptying, and reduce appetite. These combined effects make tirzepatide particularly effective for controlling blood sugar levels and promoting weight loss, making it a dual-action treatment option.